Explore our company news and media resources.

Contact us

Global Communications 
1000 Mylan Blvd. Canonsburg, PA 15317

+1. 724.514.1968

More info

Nov 23, 2020

Viatris Inc. (NASDAQ: VTRS), a new kind of healthcare company, today announced tentative approval from the U.S. Food and Drug Administration (FDA) for a New Drug Application for pediatric...

Nov 16, 2020

Combination of Mylan and Pfizer's Upjohn Business Focused on Access and Improved Patient Health PITTSBURGH, Nov. 16, 2020 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) launched today following the...

Nov 2, 2020

Mylan N.V. (NASDAQ: MYL) today announced that Bill Szablewski, CFA, has joined the company as Head of Capital Markets, in a new leadership role working closely with senior leadership. He will be...

Oct 30, 2020

Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Federal Trade Commission (the "FTC") accepted a proposed consent order, which concludes the FTC's review of the...

Sep 15, 2020

Mylan (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the companies have received final approval from the European Commission (EC) for the proposed combination of Mylan and Pfizer...

Browse press releases

Featured Stories

Providing Global Leadership to Meet the World’s Evolving Patient Needs

At Viatris, we aim to empower people worldwide to live healthier at every stage of life. And we know that in order to do this, we must be committed to providing steady leadership in a world that is constantly evolving.

Learn more

Featured News
Sep 29, 2020

We are redefining the healthcare landscape. Our unique capabilities, commitment and vision position us to help meet the world’s evolving healthcare needs through access, leadership and partnership.

Sep 29, 2020

We are uniquely positioned to help ensure more patients around the world can get the care they need to live healthier at every stage of life.

Aug 5, 2020

As a leading healthcare company, Viatris is committed to doing its part in support of public health needs amid the evolving COVID-19 pandemic.

Browse articles

In the News
Nov 17, 2020
VIATRIS™ started trading today on Nasdaq, and Executive Chairman Robert J. Coury and CEO Michael Goettler shared their excitement during an interview at Nasdaq’s global Client Experience Center, located in the heart of Times Square in New York City.
Stay Connected